PERELMAN RONALD O Insider Trading Activity

Average Profitability
3.07%
Insider Buys Quantity
86
Insider Buys Sum
$197.97M
Insider Sells Quantity
6
Insider Sells Sum
$782.9M

Insider Activity of PERELMAN RONALD O

Biography of PERELMAN RONALD O

No biography is available at this moment.

2021-12-20SalevTv Therapeutics Inc.
VTVT
director
87,000
0.154%
$1.15$100,050-26.54%
2020-12-17PurchasevTv Therapeutics Inc.
VTVT
director
625,000
0.9225%
$1.60$1M-2.36%
2020-12-10PurchasevTv Therapeutics Inc.
VTVT
director
625,000
0.893%
$1.60$1M-4.79%
2020-11-24PurchasevTv Therapeutics Inc.
VTVT
director
625,000
1.0514%
$1.60$1M+13.44%
2020-05-12PurchasevTv Therapeutics Inc.
VTVT
director
625,000
0.8555%
$1.60$1M-8.98%
2020-02-25PurchasevTv Therapeutics Inc.
VTVT
director
1.25M
1.438%
$1.60$2M-33.44%
2020-01-28PurchasevTv Therapeutics Inc.
VTVT
director
1.25M
2.1109%
$1.60$2M-2.29%
2020-01-07PurchasevTv Therapeutics Inc.
VTVT
director
1.25M
2.5998%
$1.60$2M+20.34%
2019-12-18PurchasevTv Therapeutics Inc.
VTVT
director
1.37M
4.3437%
$1.46$2M+40.13%
2019-11-26PurchasevTv Therapeutics Inc.
VTVT
director
1.37M
4.4914%
$1.46$2M+42.86%
2019-11-12PurchasevTv Therapeutics Inc.
VTVT
director
1.37M
4.3437%
$1.46$2M+38.16%
2019-10-24PurchasevTv Therapeutics Inc.
VTVT
director
1.37M
4.2053%
$1.46$2M+33.76%
2019-09-26PurchasevTv Therapeutics Inc.
VTVT
director
1.37M
4.3232%
$1.46$2M+45.83%
2019-09-18PurchasevTv Therapeutics Inc.
VTVT
director
606,061
1.8097%
$1.65$1M+22.09%
2019-09-11PurchasevTv Therapeutics Inc.
VTVT
director
606,061
2.1175%
$1.65$1M+42.86%
2019-09-04PurchasevTv Therapeutics Inc.
VTVT
director
606,061
2.413%
$1.65$1M+62.79%
2019-08-22PurchasevTv Therapeutics Inc.
VTVT
director
50,000
0.1568%
$1.38$69,000+52.55%
2019-08-19PurchasevTv Therapeutics Inc.
VTVT
director
150,000
0.4727%
$1.31$195,900+60.47%
2019-08-06PurchasevTv Therapeutics Inc.
VTVT
director
1.21M
4.8259%
$1.65$2M+52.71%
2019-07-09PurchasevTv Therapeutics Inc.
VTVT
director
1.21M
4.5112%
$1.65$2M+28.26%
Total: 64
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.